Geisinger Logo
WILKES-BARRE, Pa. and SUNNYVALE, Calif., May 3, 2021 /PRNewswire/ --
Geisinger continues to bring advanced cancer care closer to home as it is the first hospital system in the U.S. to offer Accuray Incorporated's (NASDAQ: ARAY) newest Synchrony
® technology on both the CyberKnife
® Systems to better aim radiation beams and minimize damage to non-cancerous tissue during treatment.
As part of Geisinger's expansion project at its Frank M. and Dorothea Henry Cancer Center, the health system recently began providing care using the one-of-a-kind Synchrony Motion Synchronization and Real-Time Adaptive Radiotherapy Technology on its CyberKnife S7 and Radixact Systems.
Synchrony uses artificial intelligence to adapt radiation treatment delivery in real-time to tumor movement during the treatment session, with the goal of delivering a more targeted radiation dose to the tumor, in less time, to improve outcomes. Synchrony is designed to correct the radiation beam if a tumor moves because of bodily processes such as breathing or digestion, as well as patient movement that may occur during treatment.